Heterogeneity in COVID-19 Convalescent Plasma Clinical Trials
Clin Pharmacol Ther
.
2022 May;111(5):995-1000.
doi: 10.1002/cpt.2281.
Epub 2021 Jun 17.
Authors
Mirco Müller-Olling
1
,
Ute Vahlensieck
1
,
Anneliese Hilger
1
Affiliation
1
Hematology and Transfusion Medicine, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
PMID:
34139028
PMCID:
PMC8426852
DOI:
10.1002/cpt.2281
No abstract available
MeSH terms
COVID-19 Serotherapy
COVID-19* / therapy
Clinical Trials as Topic*
Humans
Immunization, Passive
Plasma
Treatment Outcome